Read + Share
Einerhand SMH, van Dorp J, van der Heijden MS, van Rhijn BWG, et al. Re: Neoadjuvant PD-L1 plus CTLA-4 Blockade in Patients with Cisplatin-ineligible
Operable High-risk Urothelial Carcinoma. Eur Urol 2023;83:91-92.
PMID: 36210214
|
 |
|
Einerhand SMH, van Dorp J, van der Heijden MS, van Rhijn BWG, et al. Re: Neoadjuvant PD-L1 plus CTLA-4 Blockade in Patients with Cisplatin-ineligible
Operable High-risk Urothelial Carcinoma. Eur Urol 2023;83:91-92.
PMID: 36210214
|
|
|
|